223 related articles for article (PubMed ID: 21429894)
1. Toxicological evaluation of preservative-containing and preservative-free topical prostaglandin analogues on a three-dimensional-reconstituted corneal epithelium system.
Liang H; Pauly A; Riancho L; Baudouin C; Brignole-Baudouin F
Br J Ophthalmol; 2011 Jun; 95(6):869-75. PubMed ID: 21429894
[TBL] [Abstract][Full Text] [Related]
2. Multiple endpoint analysis of BAC-preserved and unpreserved antiallergic eye drops on a 3D-reconstituted corneal epithelial model.
Pauly A; Brasnu E; Riancho L; Brignole-Baudouin F; Baudouin C
Mol Vis; 2011 Mar; 17():745-55. PubMed ID: 21437201
[TBL] [Abstract][Full Text] [Related]
3. The cytotoxic effects of preserved and preservative-free prostaglandin analogs on human corneal and conjunctival epithelium in vitro and the distribution of benzalkonium chloride homologs in ocular surface tissues in vivo.
Pellinen P; Huhtala A; Tolonen A; Lokkila J; Mäenpää J; Uusitalo H
Curr Eye Res; 2012 Feb; 37(2):145-54. PubMed ID: 22049909
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo comparative toxicological study of a new preservative-free latanoprost formulation.
Pauly A; Roubeix C; Liang H; Brignole-Baudouin F; Baudouin C
Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8172-80. PubMed ID: 23150620
[TBL] [Abstract][Full Text] [Related]
5. In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells.
Guenoun JM; Baudouin C; Rat P; Pauly A; Warnet JM; Brignole-Baudouin F
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2444-50. PubMed ID: 15980234
[TBL] [Abstract][Full Text] [Related]
6. In Vivo Effects of Preservative-free and Preserved Prostaglandin Analogs: Mouse Ocular Surface Study.
Kim JH; Kim EJ; Kim YH; Kim YI; Lee SH; Jung JC; Lee KW; Park YJ
Korean J Ophthalmol; 2015 Aug; 29(4):270-9. PubMed ID: 26240512
[TBL] [Abstract][Full Text] [Related]
7. Toxicity evaluation of antiglaucoma drugs using stratified human cultivated corneal epithelial sheets.
Nakagawa S; Usui T; Yokoo S; Omichi S; Kimakura M; Mori Y; Miyata K; Aihara M; Amano S; Araie M
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5154-60. PubMed ID: 22695966
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the cytotoxic effects of ophthalmic solutions containing benzalkonium chloride on corneal epithelium using an organotypic 3-D model.
Khoh-Reiter S; Jessen BA
BMC Ophthalmol; 2009 Jul; 9():5. PubMed ID: 19638217
[TBL] [Abstract][Full Text] [Related]
9. Corneal epithelial cell viability following exposure to ophthalmic solutions containing preservatives and/or antihypertensive agents.
Whitson JT; Petroll WM
Adv Ther; 2012 Oct; 29(10):874-88. PubMed ID: 23065664
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the ocular tolerability of a latanoprost cationic emulsion versus conventional formulations of prostaglandins: an in vivo toxicity assay.
Liang H; Baudouin C; Faure MO; Lambert G; Brignole-Baudouin F
Mol Vis; 2009 Aug; 15():1690-9. PubMed ID: 19710954
[TBL] [Abstract][Full Text] [Related]
11. Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells.
Ammar DA; Noecker RJ; Kahook MY
Adv Ther; 2010 Nov; 27(11):837-45. PubMed ID: 20931366
[TBL] [Abstract][Full Text] [Related]
12. Corneal damage and its recovery after instillation of preservative-free versus preserved latanoprost eye drops.
Inoue D; Mohamed YH; Uematsu M; Kitaoka T
Cutan Ocul Toxicol; 2020 Jun; 39(2):158-164. PubMed ID: 32295438
[No Abstract] [Full Text] [Related]
13. In vitro comparison of cytoprotective and antioxidative effects of latanoprost, travoprost, and bimatoprost on conjunctiva-derived epithelial cells.
Guenoun JM; Baudouin C; Rat P; Pauly A; Warnet JM; Brignole-Baudouin F
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4594-9. PubMed ID: 16303954
[TBL] [Abstract][Full Text] [Related]
14. Conjunctival and corneal reactions in rabbits following short- and repeated exposure to preservative-free tafluprost, commercially available latanoprost and 0.02% benzalkonium chloride.
Liang H; Baudouin C; Pauly A; Brignole-Baudouin F
Br J Ophthalmol; 2008 Sep; 92(9):1275-82. PubMed ID: 18723745
[TBL] [Abstract][Full Text] [Related]
15. In vitro toxicity of topical ocular prostaglandin analogs and preservatives on corneal epithelial cells.
Kahook MY; Ammar DA
J Ocul Pharmacol Ther; 2010 Jun; 26(3):259-63. PubMed ID: 20565312
[TBL] [Abstract][Full Text] [Related]
16. In vitro effects of preservative-free tafluprost and preserved latanoprost, travoprost, and bimatoprost in a conjunctival epithelial cell line.
Brasnu E; Brignole-Baudouin F; Riancho L; Guenoun JM; Warnet JM; Baudouin C
Curr Eye Res; 2008 Apr; 33(4):303-12. PubMed ID: 18398704
[TBL] [Abstract][Full Text] [Related]
17. In vitro effects of preservative-free and preserved prostaglandin analogs on primary cultured human conjunctival fibroblast cells.
Kim EJ; Kim YH; Kang SH; Lee KW; Park YJ
Korean J Ophthalmol; 2013 Dec; 27(6):446-53. PubMed ID: 24311931
[TBL] [Abstract][Full Text] [Related]
18. In vitro studies of antiglaucomatous prostaglandin analogues: travoprost with and without benzalkonium chloride and preserved latanoprost.
Baudouin C; Riancho L; Warnet JM; Brignole F
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4123-8. PubMed ID: 17724196
[TBL] [Abstract][Full Text] [Related]
19. Multiple endpoint analysis of the 3D-reconstituted corneal epithelium after treatment with benzalkonium chloride: early detection of toxic damage.
Pauly A; Meloni M; Brignole-Baudouin F; Warnet JM; Baudouin C
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1644-52. PubMed ID: 19168896
[TBL] [Abstract][Full Text] [Related]
20. The preservative polyquaternium-1 increases cytoxicity and NF-kappaB linked inflammation in human corneal epithelial cells.
Paimela T; Ryhänen T; Kauppinen A; Marttila L; Salminen A; Kaarniranta K
Mol Vis; 2012; 18():1189-96. PubMed ID: 22605930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
